# Nucleo Landing Page Growth Score | YC F25 | Lazyweb

Lazyweb publishes a public search API over its indexed pages; the guide is at https://www.lazyweb.com/agent-access.

Source: https://www.lazyweb.com/yc-f25/nucleo
Source observed: 2026-10-15T19:23:33.654Z
Last checked: 2026-10-20T07:26:40.782+00:00
Indexed: 2026-10-15T22:30:54.602+00:00

---

# Nucleo Landing Page Growth Score

We assess the landing page for [Nucleo](https://nucleoresearch.com/) in the YC F25 group. Nucleo describes its product as **automated cancer diagnostics**. The report's overall Growth Score is **59**, updated **September 22, 2026**. The weakest category is **Trust**, scored **44**.

## Overall ranking and category scores

Nucleo ranks first among the six listed companies by overall score:

1. **Nucleo — 59**
2. [PathAI — 58](https://www.lazyweb.com/growth-score/site/pathai.com)
3. [Proscia — 57](https://www.lazyweb.com/growth-score/site/proscia.com)
4. [Paige — 54](https://www.lazyweb.com/growth-score/site/paige.ai)
5. [Qritive — 54](https://www.lazyweb.com/growth-score/site/qritive.com)
6. [Ibex Medical Analytics — 51](https://www.lazyweb.com/growth-score/site/ibex-ai.com)

| Category | Score |
| --- | ---: |
| [Trust](https://www.lazyweb.com/yc-f25/nucleo#gs-trust) | 44 |
| [Value props](https://www.lazyweb.com/yc-f25/nucleo#gs-value_props) | 52 |
| [CTA](https://www.lazyweb.com/yc-f25/nucleo#gs-cta) | 58 |
| [Mobile web](https://www.lazyweb.com/yc-f25/nucleo#gs-mobile_web) | 68 |
| [Information hierarchy](https://www.lazyweb.com/yc-f25/nucleo#gs-information_hierarchy) | 72 |

Use [Fix Trust](https://www.lazyweb.com/plans/checkout?plan=individual&source=growth_score_feature_build_fixes) to access the trust-fix workflow.

## Score over time

The report shows these Nucleo reports:

1. **September 22, 2026 — 59**, live report. Overall increased **25** points; Information hierarchy increased **38**; Value props increased **30**.
2. [September 1, 2026 — 34](https://www.lazyweb.com/growth-score/history/2026-09-01), first tracked report. Strongest category: Mobile web **48**. Weakest category: Value props **22**.

## Trust — 44, Poor

Trust measures proof that the product is real, competent, and safe to try.

![Nucleo mobile landing-page capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/nucleoresearch.com-mobile.jpg?v=2026-09-22T00%3A26%3A25.58%2B00%3A00)

The trust comparison records these signals:

| Company | Trust read |
| --- | --- |
| Nucleo | Product screenshot of CT-scan segmentation UI above the “BOOK A DEMO” button |
| Paige | “Paige, now a Tempus company” banner |
| Ibex Medical Analytics | Real Ibex diagnostic UI screenshot with slide heatmap analysis in the mobile hero |
| PathAI | No visible trust signal identified. |
| Qritive | MedTech Innovator Asia Pacific 2024 Finalist badge in the header |
| Proscia | Banner: “Unilabs Advances Digital Pathology Across Europe with Proscia, Shaping the Future of Precision Medicine” |

Trust ranking within the comparison:

1. Qritive — 52
2. Proscia — 52
3. Nucleo — 44
4. Paige — 42
5. PathAI — 42
6. Ibex Medical Analytics — 34

Our [Proof section builder](https://www.lazyweb.com/backlog?site=nucleoresearch.com#opt-trust-signals) helps choose proof signals and generate copy and placement for a trust section.

## Value props — 52, Fair

This category evaluates whether the title, subtitle, and hero sell the product's true value.

Nucleo's headline is shown as:

- **Title:** “Nucleo”
- **Subtitle:** “Automated cancer diagnostics”

### Working

- Names the category in three plain words
- Uses no inflated abstraction or buzzwords
- The scan-viewer screenshot hints at a real product

### Could improve

- The H1 is only the brand name and does not sell the product
- There are zero numbers, outcomes, or proof points
- The product screenshot is thumbnail-sized

Value-prop ranking:

1. Ibex Medical Analytics — 62
2. Proscia — 62
3. PathAI — 58
4. Nucleo — 52
5. Paige — 52
6. Qritive — 48

## CTA — 58, Fair

This category evaluates CTA copy, size, verb, and cost-feel.

![Nucleo CTA capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/nucleoresearch.com.jpg?v=2026-09-22T00%3A26%3A25.58%2B00%3A00)

The Nucleo CTA is **“BOOK A DEMO.”** The comparison also shows **“Watch the Video”** for Ibex Medical Analytics.

### Problems identified

- Demo booking feels costly
- The CTA has a tiny footprint relative to the headline
- Two labels—“demo” and “get started”—split the action
- There is no CTA in the desktop hero

CTA ranking:

1. Ibex Medical Analytics — 62
2. Nucleo — 58
3. Paige — 58
4. PathAI — 58
5. Qritive — 58
6. Proscia — 52

Our [CTA rewrite studio](https://www.lazyweb.com/backlog?site=nucleoresearch.com#opt-cta-writing) generates primary and secondary CTA options grounded in Nucleo's offer and visitor objections.

## Mobile web — 68, Fair

The mobile review identifies three issues:

![Mobile web annotations on the mobile capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/nucleoresearch.com-mobile.jpg?v=2026-09-22T00%3A26%3A25.58%2B00%3A00)

1. **“BOOK A DEMO” placement:** The primary CTA sits at the bottom edge of the fold, partly buried under the screenshot card instead of appearing as a clear tappable button.
2. **“GET STARTED” header pill:** Low-contrast monospace text competes with “BOOK A DEMO” below, splitting the visitor's first action between two labels.
3. **Product screenshot card:** Dense desktop diagnostic UI is reduced into the phone column; labels and sliders are illegibly small, and the card crowds the CTA it frames.

Our [Mobile fix plan](https://www.lazyweb.com/backlog?site=nucleoresearch.com#opt-mobile-web) converts these findings into a prioritized implementation checklist.

## Information hierarchy — 72, Fair

The hierarchy review identifies three issues:

![Information hierarchy annotations on the desktop capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/nucleoresearch.com.jpg?v=2026-09-22T00%3A26%3A25.58%2B00%3A00)

1. **“BOOK A DEMO” caption:** The primary CTA reads like an image caption—small monospace text in the bottom-right corner, outside the scan path and without button affordance.
2. **Subtitle contrast:** “Automated cancer diagnostics” is white on a pale pastel band, weakening the only line explaining what Nucleo does.
3. **Product screenshot thumbnail:** The diagnostic UI preview is too small to communicate the product, while visually competing with the CTA text pinned to it.

Our [Layout priority plan](https://www.lazyweb.com/backlog?site=nucleoresearch.com#opt-information-hierarchy) turns these callouts into a sequenced keep, move, merge, or remove plan.

## Competitors

The competitors are inferred from product, audience, and value proposition:

1. **Nucleo — 59**
2. [PathAI — 58](https://www.lazyweb.com/growth-score/site/pathai.com)
3. [Proscia — 57](https://www.lazyweb.com/growth-score/site/proscia.com)
4. [Paige — 54](https://www.lazyweb.com/growth-score/site/paige.ai)
5. [Qritive — 54](https://www.lazyweb.com/growth-score/site/qritive.com)
6. [Ibex Medical Analytics — 51](https://www.lazyweb.com/growth-score/site/ibex-ai.com)

---

[Read this page’s summary](https://www.lazyweb.com/api/public/v1/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-f25%2Fnucleo&trace=t_bc7e1c4e5b07)

## Ask a follow-up about this page

Need a more specific answer? Ask the exact question you have. It returns a fresh, cited answer from Lazyweb’s knowledge base. No account or API key required.

Open this URL with your own question, URL-encoded. Only q is required. No account or setup.

`GET https://www.lazyweb.com/agent/faq?q={question}&trace=t_bc7e1c4e5b07`

[Tool guide and examples](https://www.lazyweb.com/agent-access) · [OpenAPI](https://www.lazyweb.com/api/public/v1/openapi.json) · [Page TLDR form](https://www.lazyweb.com/agent-tools/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-f25%2Fnucleo). Opening a form does not execute a tool.